These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23099437)

  • 1. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
    Akbari MR; Kluźniak W; Rodin R; Li S; Wokołorczyk D; Royer R; Kashyap A; Menkiszak J; Lubinski J; Narod SA; Cybulski C
    Breast Cancer Res Treat; 2012 Dec; 136(3):907-9. PubMed ID: 23099437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer.
    Akbari MR; Anderson LN; Buchanan DD; Clendenning M; Jenkins MA; Win AK; Hopper JL; Giles GG; Nam R; Narod S; Gallinger S; Cleary SP
    Cancer Epidemiol; 2013 Aug; 37(4):424-7. PubMed ID: 23541221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease.
    Habel LA; Sakoda LC; Achacoso N; Ma XJ; Erlander MG; Sgroi DC; Fehrenbacher L; Greenberg D; Quesenberry CP
    Breast Cancer Res; 2013 Mar; 15(2):R24. PubMed ID: 23497539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.
    Cai Q; Wang X; Li X; Gong R; Guo X; Tang Y; Yang K; Niu Y; Zhao Y
    Oncotarget; 2015 Dec; 6(39):42312-21. PubMed ID: 26517352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
    Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
    Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study.
    Jansen MP; Sieuwerts AM; Look MP; Ritstier K; Meijer-van Gelder ME; van Staveren IL; Klijn JG; Foekens JA; Berns EM
    J Clin Oncol; 2007 Feb; 25(6):662-8. PubMed ID: 17308270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance.
    Goetz MP; Suman VJ; Couch FJ; Ames MM; Rae JM; Erlander MG; Ma XJ; Sgroi DC; Reynolds CA; Lingle WL; Weinshilboum RM; Flockhart DA; Desta Z; Perez EA; Ingle JN
    Clin Cancer Res; 2008 Sep; 14(18):5864-8. PubMed ID: 18794098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
    Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
    Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
    Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
    Ma XJ; Hilsenbeck SG; Wang W; Ding L; Sgroi DC; Bender RA; Osborne CK; Allred DC; Erlander MG
    J Clin Oncol; 2006 Oct; 24(28):4611-9. PubMed ID: 17008703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
    Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
    Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome.
    Jerevall PL; Brommesson S; Strand C; Gruvberger-Saal S; Malmström P; Nordenskjöld B; Wingren S; Söderkvist P; Fernö M; Stål O
    Breast Cancer Res Treat; 2008 Jan; 107(2):225-34. PubMed ID: 17453342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
    Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
    Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
    Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
    Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
    Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
    Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
    BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
    Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
    Wang Z; Dahiya S; Provencher H; Muir B; Carney E; Coser K; Shioda T; Ma XJ; Sgroi DC
    Clin Cancer Res; 2007 Nov; 13(21):6327-34. PubMed ID: 17975144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HOXB13 p.Gly84Glu variant observed in an extended five generation high-risk prostate cancer pedigree supports risk association for multiple cancer sites.
    Cannon-Albright LA; Stevens J; Teerlink CC; Agarwal N
    Cancer Epidemiol; 2020 Dec; 69():101834. PubMed ID: 33099213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
    Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
    Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.